Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of raltitrexed and cisplatin
neoadjuvant chemotherapy followed by concurrent radiotherapy with raltitrexed and cisplatin
in patients with locally advanced nasopharyngeal carcinoma.